PD-L2 protein expression was markedly enhanced in TSC2(−) AML cells compared to that in the wild-type control cells (Fig. 5c), and PD-L2 expression was ablated when NF-κB was inhibited with 5 μM BMS345541 (Fig. 5 d). The gene discussed is TSC2; the disease is acute myeloid leukemia.